MedTrace Logo

A Multicenter Collaborative Study on the Clinical Features, Expression Profiling, and Quality of Life of Infantile Onset FSHD

NCT01437345 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2017-10-11

No results posted yet for this study

Summary

This study is an observational study that aims to advance our knowledge on infantile onset FSHD. The study will include 50 participants of all ages who have presented with symptoms of FSHD between birth and 10 years of age. Study participation will involve a single day of assessments at one of the participating CINRG centers (to include physical exam, cognitive testing, eye exam, hearing test, strength testing and speech evaluations). The procedures may be split over additional days for scheduling purposes.

Conditions

Sponsors & Collaborators

  • FSH Society, Inc.

    collaborator INDUSTRY

  • FSHD Global Research Foundation

    collaborator OTHER

  • Muscular Dystrophy Canada

    collaborator OTHER

  • aTyr Pharma, Inc.

    collaborator INDUSTRY

  • Cooperative International Neuromuscular Research Group

    lead NETWORK

Principal Investigators

  • Jean K Mah, MD, MS · Alberta Children's Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • United States
  • Australia
  • Canada
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01437345 on ClinicalTrials.gov